Cellular Dynamics International says it has signed a Center of Excellence agreement with AstraZeneca to speed the pace of drug discovery by using CDI’s stem cell lines and tissue cells. It is the third Center of Excellence agreement with a major, global pharmaceutical company for CDI, the Madison company founded by UW-Madison stem cell pioneer James Thomson. Read the full Wisconsin State Journal story here.